Republican victory in Massachusetts a blow for Obama health reform plans; not a happy first anniversary present

20 January 2010

The victory of little-known Republican Scott Brown in yesterday's US Senate elections in the state of Massachusetts puts US President Barack Obama's health care reform dreams in danger, and the blow comes as the President today celebrates his first year in office.

In what was a strong voter turnout - despite snow and drizzle in the area, Mr Brown won by a majority of 51.9%. Just weeks ago, leading opponent state Attorney General, Democrat Martha Coakley, had a double-digit lead in polls and seemed destined to win.

The Republican victory in MA last night removes the Democrats' 60 seat filibuster-proof Senate majority. This potentially increases the risk that Democrats who were in favor of reform now back down. The state had been held by Democrats, notably Senator Edward Kennedy - who died last year, for almost half a century. The state is also home to more than 400 biotechnology companies, which stand to lose out on provisions for patent exclusivity relating to biosimilars approvals, which the President wants to reduce from the 12 years proposed by the current legislation packages before Congress.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight





More Features in Pharmaceutical